TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma
Niranjana D. Amin(National Institute of Neurological Disorders and Stroke), Zhengping Zhuang(National Cancer Institute)
Cited by 2
Related Papers
Somatic<i>HIF2A</i>Gain-of-Function Mutations in Paraganglioma with Polycythemia
|New England Journal of Medicine|2012|391
Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
|Oncotarget|2017|81
Cyclin-Dependent Kinase 5 Phosphorylation of Human Septin SEPT5 (hCDCrel-1) Modulates Exocytosis
|Journal of Neuroscience|2008|80
Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones
|Proceedings of the National Academy of Sciences|2012|78
Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones
|Proceedings of the National Academy of Sciences|2013|45